Evidence map›Paper›PMID 18992263›Full record

ArticleMutation research2009

Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Martha L Slattery, Roger K Wolff, Karen Curtin, Frank Fitzpatrick, Jennifer Herrick, John D Potter, Bette J Caan, Wade S Samowitz

Abstract read
In one paragraph

Article in Mutation research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 7 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 7 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2016
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Trial
  9. Trial
  10. Vitamin D Status,Nutrients · 2023
    Article
  11. Review
  12. Article
  13. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Martha L SlatteryDepartment of Medicine, University of Utah, Salt Lake City, UT 84108, USA. marty.slattery@hsc.utah.edu
Roger K Wolff
Karen Curtin
Frank Fitzpatrick
Jennifer Herrick
John D Potter
Bette J Caan
Wade S Samowitz
University of Utah · USFred Hutch Cancer Center · USHuntsman Cancer Institute · USKaiser Permanente Walnut Creek Medical Center · US

Funding

DIET, ACTIVITY &REPRODUCTION--RISKS FOR RECTAL CANCERR01CA048998 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA L · 1991 to 2012
$7.9M
DIET AND SOMATIC MUTATIONS IN COLON CANCERR01CA061757 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA L · 1995 to 2007
$3.8M
Growth Factors and Colon CancerR01CA085846 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA L · 2001 to 2006
$2.2M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067000 · PC · UNIVERSITY OF UTAH · PI WIGGINS, CHARLES L · 1996 to 2000
$1.3M
DIET, ACTIVITY &REPRODUCTION--RISKS FOR RECTAL CANCERU01CA048998 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA OR MARTY L · 1997 to 1999
–
NCI NIH HHS CA48998NCI NIH HHS CA61757NCI NIH HHS CA85846NCI NIH HHS N01-PC-67000NCI NIH HHS R01 CA048998NCI NIH HHS R01 CA061757NCI NIH HHS R01 CA085846NCI NIH HHS U01 CA048998
6 · The paper itself

Abstract

Variation in genes associated with serum levels of proteins may be useful for examining specific disease pathways. Using data from a large study of colon cancer, we examine genetic variants in insulin, inflammation, estrogen, metabolizing enzymes, and energy homeostasis genes to explore associations with microsatellite instability (MSI), CpG Island methylator phenotype (CIMP), mutations of p53 in exons 5 through 8, and mutations in codons 12 and 13 of Ki-ras. Insulin-related genes were associated with CIMP-positive and MSI tumors, with the strongest associations among aspirin users. The Fok1 vitamin D receptor (VDR) polymorphism was associated with CIMP-positive/Ki-ras-mutated tumors; the Poly A and CDX2 VDR polymorphisms were associated only with Ki-ras-mutated tumors. NAT2 was associated with CIMP-positive/Ki-ras-mutated tumors but not with MSI tumors. The TCF7L2 rs7903146 polymorphism was associated with p53 mutated tumors. Most associations varied by recent aspirin/NSAID use: IL6 rs1800796 and rs1800795 polymorphisms were associated inversely with tumor mutations in the presence of aspirin/NSAIDs; POMC significantly reduced risk of Ki-ras-mutated tumors when aspirin/NSAIDs were not used; the TCF7L2 rs7903146 was associated with reduced risk of Ki-ras-mutated tumors in the presence of aspirin and increased risk in the absence of aspirin. These data, although exploratory, identify specific tumor subsets that may be associated with specific exposures/polymorphism combinations. The important modifying effects of aspirin/NSAIDs on associations with genetic polymorphisms reinforce the underlying role of inflammation in the etiology of colon cancer.

Indexed as

AdultAgedAnti-Inflammatory Agents, Non-SteroidalArylamine N-AcetyltransferaseAspirinCase-Control StudiesColonic NeoplasmsCpG IslandsEpigenesis, GeneticExonsFemaleHumansInterleukin-6MaleMicrosatellite InstabilityMiddle AgedAnti-Inflammatory Agents, Non-SteroidalArylamine N-AcetyltransferaseAspirinInterleukin-6NAT2 protein, humanPro-OpiomelanocortinReceptors, CalcitriolTCF7L2 protein, humanTCF Transcription FactorsTranscription Factor 7-Like 2 ProteinTumor Suppressor Protein p53

Identifiers

PMID18992263
PMCPMC2907671
OpenAlexW2011817972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.